SCHEMBL29566328

SCHEMBL29566328

Cn1cc(S(=O)(=O)Nc2nc(Oc3ccccc3)cc(C3CCC(F)(F)CC3)n2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 6/20 0.40
▸ HTR7 P34969 6/20 0.40
▸ DRD2 P14416 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ SLC8A1 P32418 1/20 0.36
▸ TSHR P16473 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PCK1 P35558 1/20 0.33
▸ WNT1 P04628 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ EGFR P00533 2/20 0.33
▸ FGFR1 P11362 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ IRAK1 P51617 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309397 1.00 HTR1A (0.40) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL26807484 0.90 HTR1A (0.43) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL29566649 0.89 HTR1A (0.42) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL26807354 0.89 HTR1A (0.42) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL26807485 0.87 HTR1A (0.40) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL26807482 0.86 HTR1A (0.40) HTR1AHTR7SLC8A1TSHRSMN1; SMN2
SCHEMBL26807731 0.84 HRH3 (0.39) HTR1AHTR7WNT1GSK3BDYRK1A
SCHEMBL29567582 0.83 HTR1A (0.38) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL24309633 0.83 HTR1A (0.38) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL26807486 0.82 HTR1A (0.41) HTR1AHTR7DRD2HTR6SLC8A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback